GNTAGenenta Science S.p.A. American Depositary Shares
ADRCNasdaq (XNAS)·USD
Identity
- Security key
- 16131
- Ticker
- GNTA
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-12-15
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- GNTA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $62,681,915.4
- Shares outstanding (class)
- 23,591,020
- Shares outstanding (weighted)
- 48,216,858
- SIC
- —
- Employees
- 9
- Location
- —
- Homepage
- https://www.genenta.com
- Description
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
Market cap and share counts drift.